Sirtex Medical Limited Given Hold Rating at Morningstar (SRX)
Sirtex Medical Limited (ASX:SRX)‘s stock had its “hold” rating reaffirmed by research analysts at Morningstar in a report released on Sunday, Stock Ratings News reports.
Shares of Sirtex Medical Limited (ASX:SRX) opened at 15.880 on Friday. Sirtex Medical Limited has a one year low of A$9.540 and a one year high of A$16.430. The stock’s 50-day moving average is A$15.81 and its 200-day moving average is A$13.60. The company has a market cap of A$891.0 million and a P/E ratio of 42.11.
Sirtex Medical Limited is a biotechnology and medical device company. The Company is engaged in manufacturing and to distribute liver cancer treatments utilizing particle technology to approved markets in Asia-Pacific, Europe and the United States.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.